About this event
The main purpose of the event is to present the findings of the recently published study on optimising public procurement of medicines. This study analysed the current practices in public procurement of medicines across 32 European countries (EU-27 plus EEA/EFTA countries and the UK). During the webinar, the study team will present the findings of the study, including the possible impact of procurement practices on access to medicines, security of supply, competition, protecting the environment and supporting crisis preparedness. In addition, the presentation will cover the potential of best practices for optimising public procurement of medicines in Europe. The event will allow for discussion with invited experts and wider stakeholder audiences on pharmaceutical procurement practices in Europe.
Please note that this is a pre-registration link and will not take you to the meeting itself
- medicinal product